Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2024 is 70.18% vs -22.45% in Jun 2024
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is -11.76% vs -25.93% in Jun 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2024 is -51.02% vs -13.95% in Jun 2024
Interest
QoQ Growth in quarter ended Sep 2024 is 0.00% vs -33.33% in Jun 2024
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
Compare Quarterly Results Of Dali Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2024 is 70.18% vs -22.45% in Jun 2024
YoY Growth in quarter ended Sep 2024 is 48.09% vs -56.19% in Sep 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2024 is -11.76% vs -25.93% in Jun 2024
YoY Growth in quarter ended Sep 2024 is -65.22% vs -53.33% in Sep 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2024 is -51.02% vs -13.95% in Jun 2024
YoY Growth in quarter ended Sep 2024 is -270.00% vs -766.67% in Sep 2023
Quarterly - Interest
QoQ Growth in quarter ended Sep 2024 is 0.00% vs -33.33% in Jun 2024
YoY Growth in quarter ended Sep 2024 is -50.00% vs 0.00% in Sep 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2024 has improved from Jun 2024
YoY Growth in quarter ended Sep 2024 has improved from Sep 2023






